Healthcare Provider Charges and Charge-Based Payment Systems ◾ 63
In Chapter 6, we will look at this case study again from a purely compliance perspective,
which involves the concept of price xing. For our purposes, do you think Sylvia will be inu-
enced to raise the charge above the guesstimated $560.00? Will the charge chosen correlate to the
Medicare CCR as developed through the cost report? Will this charge appear as reasonable from
a patient’s perspective? While the answers to these questions are subjective, setting charges for
healthcare services is less than a precise process.
Let us join Sylvia, the chargemaster coordinator at the ctitious Apex Medical Center. For this
case study, assume that the CCR for these devices is 0.40 as derived from the Medicare cost report.
Case Study 3.24: Pricing Drug-Eluting Stents
A new drug-eluting stent is starting to be used for coronary (and vascular in the future) catheter-
izations. e acquisition cost for the stent is $2,800.00. Because the CCR for Apex is 0.40, for
Medicare patients the charge is $2,800.00/0.40, which equals $7,000.00. For self-pay patients, the
top tier in a graduated pricing scheme is to multiply the $2,800.00 by 1.50, which equals $4,200.00.
Of course, there is a managed care contract that pays 100 percent of the cost for these stents, but
according to the contract, the hospital can only mark up the charge to 10 percent above the acquisi-
tion cost. us, a price of $2,800.00 times 1.10 or $3,080.00 is used for this payer contract.
Among the questions raised in this case study, there are two that should be mentioned. First,
there should be an immediate concern regarding why the Medicare beneciaries are being charged
more than certain other patients. Second, the $7,000.00 charge for Medicare seems quite high.
e rst concern involves the Medicare charging rule. Generally, Medicare patients should not
be charged more than other patients. e second concern involves a seemingly high charge. is
high charge results from the overall charge structure at Apex. In this case, the CCR of 0.40 means
that Apex’s charge structure is relatively high because this CCR represents a 2.50 multiplying fac-
tor when costs are marked up to charges. Because CMS will take the $7,000.00 and then convert
it back into costs by multiplying by 0.40, that is, 0.40 * $7,000.00 = $2,800.00, Apex has little
choice but to charge this amount.
In some cases, hospitals may use only a single set of charges for everyone and thus use the seem-
ingly high Medicare charge. is approach will tend to engender public comment and consternation.
Healthcare Provider Charges and Public Scrutiny
Transparent pricing is one of the later developments in the whole area of setting charges for
healthcare services and products. Individuals who have health insurance are often oblivious to
the charges because their insurance coverage has already negotiated some sort of a discounted
arrangement by limiting allowed charges. However, for those who are uninsured or underinsured,
the charges for even seemingly minor encounters can seem daunting.
e availability of charges to the public, in many cases, is not particularly illuminating.
Certainly, knowing what a particular physician or clinic charges for a routine visit, whatever con-
stitutes a routine visit, can be useful. Looking at a hospital’s chargemaster with thousands of line
items will make little sense to patients. When patients are shopping for healthcare services, they
will be much more interested in the total charge for a particular procedure or tests. While some
healthcare providers do provide charges for packages of services, this is not yet the norm.
Case Study 3.25: Packaging Pricing at the Apex Medical Center
For a number of dierent surgical services, the Apex Medical Center has been receiving more
requests from patients for a at-fee charge arrangement. One of the areas is for cataract surgery.